Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Syneos Health, Inc. SYNH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$72.00
+67.5%

Syneos Health, Inc. (SYNH) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $42.98. It has a SharesGrow Score of 67/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Analyst consensus target is SYNH = $72 (+67.5% upside).

Financials: revenue is $5.4B, +5.3%/yr average growth. Net income is $266M, growing at +27.4%/yr. Net profit margin is 4.9% (thin). Gross margin is 23.3% (+1.3 pp trend).

Balance sheet: total debt is $2.9B against $3.5B equity (Debt-to-Equity (D/E) ratio 0.83, moderate). Current ratio is 1.13 (adequate). Debt-to-assets is 35.4%. Total assets: $8.2B.

Analyst outlook: 12 / 24 analysts rate SYNH as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 93/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 49/100 (Partial), Future 64/100 (Pass), Income 30/100 (Fail).

$72.00
▲ 67.52% Upside
Average Price Target
Based on 24 Wall Street analysts offering 12-month price targets for Syneos Health, Inc., the average price target is $72.00, with a high forecast of $105.00, and a low forecast of $25.00.
Highest Price Target
$105.00
Average Price Target
$72.00
Lowest Price Target
$25.00

SYNH SharesGrow Score Overview

67/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 93/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 49/100
Gross margin is + market cap
FUTURE 64/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SYNH

✓
VALUE Pass
93/100
SYNH trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $72, implying +67.5% from the current price $43. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
83/100
SYNH: +5.3%/yr revenue is, +27.4%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
SYNH: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet SYNH: Debt-to-Equity (D/E) ratio 0.83 (moderate), Current ratio is 1.13 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
49/100
SYNH: Gross margin is 23.3% (+1.3 pp trend), $4B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 49/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
64/100
Analyst outlook: 12 / 24 analysts rate SYNH as buy (50%). Analyst consensus target is $72 (+67.5% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
SYNH: Net profit margin is 4.9%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range22.894-52.23
Volume6.7M
Avg Volume (30D)1.32M
Market Cap$4.46B
Beta (1Y)1.58
Share Statistics
EPS (TTM)2.57
Shares Outstanding$102.97M
IPO Date2014-11-07
Employees28,768
CEOMichelle Keefe
Financial Highlights & Ratios
Revenue (TTM)$5.39B
Gross Profit$1.25B
EBITDA$699.99M
Net Income$266.5M
Operating Income$403.19M
Total Cash$112M
Total Debt$2.9B
Net Debt$2.79B
Total Assets$8.2B
Price / Earnings (P/E)16.7
Price / Sales (P/S)0.83
Analyst Forecast
1Y Price Target$77.50
Target High$105.00
Target Low$25.00
Upside+80.3%
Rating ConsensusBuy
Analysts Covering24
Buy 50% Hold 46% Sell 4%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS87166B1026

Price Chart

Track all markets on TradingView
SYNH
Syneos Health, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Diagnostics & Research
22.89 52WK RANGE 52.23

People Also View

IQV
IQV
IQVIA Holdings Inc.
$175.28
+1.91%
 MTD
MTD
Mettler-Toledo International Inc.
$1,341.53
-0.32%
 LH
LH
Laboratory Corporation of America Holdings
$268.87
+1.78%
 MEDP
MEDP
Medpace Holdings, Inc.
$520.00
+3.74%
 CRL
CRL
Charles River Laboratories International, Inc.
$179.31
+0.54%
 ICLR
ICLR
ICON Public Limited Company
$113.06
+2.44%
 QGEN
QGEN
Qiagen N.V.
$41.76
-0.36%
 SHC
SHC
Sotera Health Company
$15.93
+1.46%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message